Earnings Call · Q3 FY2021·2021-11-04

Q3 21EPS -21.41%·Rev n/aQ2 21EPS -46.15%·Rev n/aQ1 21EPS +15.28%·Rev n/aQ4 20EPS -81.21%·Rev n/a⚠ consensus missing

NOVAVAX INC NVAX

Silvia Taylor — Investor Relations

Stanley C. Erck — President and Chief Executive Officer

Over the past week alone, we completed submissions to 6 regulatory agencies in the following markets

John Trizzino — Head of Manufacturing

Filip Dubovsky — Chief Medical Officer

James Kelly — Chief Financial Officer

+8.7%1d on move date+8.6% vs SPY3d+3.1%5d+6.7%

Research tier

Behavioral profile computed for 6 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more NVAX calls or request research access.

More NVAX calls Browse calls Request research access